Post-approval studies (Phase 4)Study completedNCT02286063
What this trial is testing
Ambulatory Oxygen in Fibrotic Lung Disease (FLD) (AmbOx)
Who this might be right for
Lung; Disease, Fibroid (Chronic)
Royal Brompton & Harefield NHS Foundation Trust 70